Proliferative vitreoretinopathy-developments in adjunctive treatment and retinal pathology

D G Charteris1, C S Sethi, G P Lewis

  • 1Moorfields Eye Hospital NHS Trust City Road London EC1V 2PD UK. david.charteris@moorfields.nhs.uk

Summary

Proliferative vitreoretinopathy (PVR) management remains challenging, with surgery often yielding poor visual outcomes. Future research focuses on adjunctive treatments to control cellular proliferation and improve vision in retinal disease.